Shares of Divi’s Labs surged 4% to the touch a day’s excessive of Rs 6,764.00 on twenty sixth Might after the corporate introduced that it had inked a long-term manufacturing and provide settlement with a world pharmaceutical firm.
Beneath the deal, Divi’s will manufacture and provide superior intermediates, with business phrases agreed by each events.
The unnamed buyer expects important income contribution from this long-term settlement.
Capability growth underneath the deal will price Rs 650–750 crore, funded by phase-wise advances from the client.
The corporate reported a 23% year-over-year (YoY) rise in internet revenue to Rs 662 crore and a 12% improve in income to Rs 2,585 crore for FY25.
Divi’s Labs declared a ultimate dividend of Rs 30 per share for FY25, with twenty fifth July 2025 because the file date.
At 1:31 PM, the shares of DIvi’s Labs had been buying and selling 3.71% increased at Rs 6,723.50 on NSE.
Keep Forward with Divi’s Labs. Ask the Analyst.
Unicorn Alerts’ IPO screener helps you establish promising preliminary public choices. Obtain Unicorn Alerts and get forward of the curve! Signal Up Now & Discover Your Subsequent IPO Gem!
